Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- 5-fluorocytosine
- CAS 76095-16-4
- CGP 19835A
- FAMP
- Hearing impaired: 2% - 6%
- Fe(III
- Gd-DTPA
- Ge-132
- K779
- Deafness
- Hearing impaired: postmarketing
- L-Dmp
- Octreotide
- Deafness
- Hearing impaired
- PGE2
- Photofrin II
- T-A2-3
- UDCA
- Vancocine
- Deafness
- Hearing impaired: postmarketing
- acamprosate
- acitretin
- amikacin
- High frequency deafness
- Hearing impaired
- amphotericin B
- Deafness
- Hearing impaired
- anthracycline
- aripiprazole
- Deafness
- Hearing impaired
- aspirin
- atorvastatin
- azithromycin
- Deafness: postmarketing
- Hearing impaired: postmarketing, 0.4% - 1.1%
- betaxolol
- bexarotene
- boceprevir
- Deafness: uncommon
- Hearing impaired: uncommon
- bortezomib
- Deafness
- Hearing impaired: 1%
- bupropion
- butorphanol
- cabozantinib
- caffeine
- capecitabine
- Deafness
- Hearing impaired
- capreomycin
- carbamazepine
- Hearing impaired: very rare
- carboplatin
- celecoxib
- Deafness
- Hearing impaired
- cetirizine
- cevimeline
- chlorhexidine gluconate
- cidofovir
- Hearing impaired: postmarketing
- ciprofloxacin
- Hearing impaired: very rare, postmarketing, rare, uncommon
- cisplatin
- Deafness
- High frequency deafness
- Hearing impaired
- citalopram
- clarithromycin
- Deafness: postmarketing
- Hearing impaired: postmarketing
- clofarabine
- clomiphene citrate
- clomipramine
- clopidogrel
- Hearing impaired: postmarketing
- copolymer 1
- cyclophosphamide
- Deafness: postmarketing
- Hearing impaired: postmarketing
- cytarabine
- Deafness: 3%
- Hearing impaired: 5.84% - 18.2%
- deferasirox
- High frequency deafness
- Hearing impaired: uncommon
- deprenyl
- diclofenac
- Hearing impaired: very rare
- diflunisal
- Hearing impaired: postmarketing
- docetaxel
- doxazosin
- doxepin
- erythromycin
- erythromycin stearate
- eslicarbazepine acetate
- estradiol
- ethacrynic acid
- etodolac
- Deafness: postmarketing
- Hearing impaired
- febuxostat
- flecainide
- fluconazole
- fludarabine
- Hearing impaired: 2% - 6%
- flumazenil
- fluoxetine
- flurbiprofen
- fluvoxamine
- Deafness: rare, infrequent
- fosfomycin
- Hearing impaired: postmarketing
- fosfomycin trometamol
- Hearing impaired: postmarketing
- fosphenytoin
- Deafness: infrequent, 0% - 2.2%
- furosemide
- Deafness
- Hearing impaired
- gabapentin
- Deafness: infrequent
- Hearing impaired: infrequent
- gadobenate dimeglumine
- gadopentetate
- Hearing impaired: postmarketing
- ganciclovir
- gemcitabine
- gentamicin
- glibenclamide
- gliclazide
- hydrocodone
- hydroxychloroquine
- ibandronate
- ibuprofen
- ifosfamide
- Deafness: postmarketing
- Hearing impaired: postmarketing
- imatinib
- Hearing impaired: uncommon
- indomethacin
- iodixanol
- iopamidol
- itraconazole
- Hearing impaired: postmarketing, 3.3%
- kanamycin
- ketoprofen
- ketorolac
- ketorolac tromethamine
- Deafness
- Hearing impaired: postmarketing
- lamivudine
- lamotrigine
- lansoprazole
- lenalidomide
- Deafness: postmarketing
- Hearing impaired: postmarketing
- maraviroc
- mefenamic acid
- mefloquine
- Hearing impaired: postmarketing
- memantine
- metoprolol
- Deafness: very rare
- Hearing impaired: very rare
- mirtazapine
- misoprostol
- monomycin
- moxifloxacin
- Deafness: postmarketing
- Hearing impaired: postmarketing
- mycophenolate mofetil
- mycophenolic acid
- naproxen
- Hearing impaired: postmarketing
- nefazodone
- nilotinib
- norfloxacin
- Hearing impaired: postmarketing
- ofloxacin
- Hearing impaired: postmarketing
- olanzapine
- oxaliplatin
- Deafness: postmarketing, rare
- oxaprozin
- paclitaxel
- Hearing impaired: very rare, postmarketing
- pantoprazole
- paroxetine
- pegaptanib
- Deafness
- Hearing impaired
- pegaptanib sodium
- pentostatin
- pergolide
- phenylbutyric acid
- phenytoin
- Deafness: infrequent, 0% - 2.2%
- pilocarpine
- piroxicam
- Deafness
- Hearing impaired
- posaconazole
- pramipexole
- Deafness
- Hearing impaired
- pravastatin
- pregabalin
- procarbazine
- propafenone
- quetiapine
- quinidine
- Deafness
- High frequency deafness
- Hearing impaired
- rabeprazole
- ramipril
- ramiprilat
- rapamycin
- rasagiline
- reserpine
- retinoic acid
- Hearing impaired: postmarketing
- Deafness: postmarketing
- ribavirin
- Hearing impaired: postmarketing, common
- riluzole
- risperidone
- Deafness
- Hearing impaired
- ritonavir
- rivastigmine
- rizatriptan
- ropinirole
- roxithromycin
- Deafness
- Hearing impaired
- salicylate
- salmon calcitonin acetate
- Hearing impaired: postmarketing
- salsalate
- saquinavir
- sildenafil
- Deafness: postmarketing, rare
- Hearing impaired
- sitaxsentan
- streptomycin
- sulfasalazine
- sumatriptan
- Deafness: postmarketing
- Hearing impaired
- tacrolimus
- Deafness: postmarketing
- Hearing impaired: very rare, postmarketing, uncommon
- tadalafil
- telavancin
- temozolomide
- Deafness: uncommon
- Hearing impaired: common, 1% - 4%
- terbinafine
- Hearing impaired: postmarketing
- thalidomide
- Deafness: postmarketing
- Hearing impaired: postmarketing
- thiotepa
- tiagabine
- tizanidine
- Deafness: infrequent, frequent
- tobramycin
- Deafness
- High frequency deafness: common
- Hearing impaired: postmarketing, common
- topiramate
- Deafness
- Hearing impaired: 1% - 2%
- tramadol
- trazodone
- Hearing impaired: infrequent
- triazolam
- v 1784
- Deafness: postmarketing
- Hearing impaired: uncommon
- valganciclovir
- valproate
- Deafness
- Hearing impaired: postmarketing
- varenicline
- venlafaxine
- vigabatrin
- vinblastine
- vincristine
- vinorelbine
- Hearing impaired: postmarketing, 4% - 18%
- voriconazole
- Deafness
- Hearing impaired: rare
- zalcitabine
- zaleplon
- zidovudine
- Hearing impaired: postmarketing
- zidovudine/lamivudine
- zonisamide
|